675 related articles for article (PubMed ID: 16891499)
1. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development.
Mena A; Plasencia V; García L; Hidalgo O; Ayestarán JI; Alberti S; Borrell N; Pérez JL; Oliver A
J Clin Microbiol; 2006 Aug; 44(8):2831-7. PubMed ID: 16891499
[TBL] [Abstract][Full Text] [Related]
2. Emergence of CTX-M-15 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in Bosnia and Herzegovina.
Dedeic-Ljubovic A; Hukic M; Pfeifer Y; Witte W; Padilla E; López-Ramis I; Albertí S
Clin Microbiol Infect; 2010 Feb; 16(2):152-6. PubMed ID: 19686282
[TBL] [Abstract][Full Text] [Related]
3. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
[TBL] [Abstract][Full Text] [Related]
5. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
Ensor VM; Shahid M; Evans JT; Hawkey PM
J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
[TBL] [Abstract][Full Text] [Related]
6. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
[TBL] [Abstract][Full Text] [Related]
7. Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain.
Leavitt A; Chmelnitsky I; Ofek I; Carmeli Y; Navon-Venezia S
J Antimicrob Chemother; 2010 Feb; 65(2):243-8. PubMed ID: 19939824
[TBL] [Abstract][Full Text] [Related]
8. Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital.
Cubero M; Cuervo G; Dominguez MÁ; Tubau F; Martí S; Sevillano E; Gallego L; Ayats J; Peña C; Pujol M; Liñares J; Ardanuy C
BMC Microbiol; 2015 Sep; 15():177. PubMed ID: 26335352
[TBL] [Abstract][Full Text] [Related]
9. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
[TBL] [Abstract][Full Text] [Related]
10. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15.
Lytsy B; Sandegren L; Tano E; Torell E; Andersson DI; Melhus A
APMIS; 2008 Apr; 116(4):302-8. PubMed ID: 18397465
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
Kao CY; Udval U; Huang YT; Wu HM; Huang AH; Bolormaa E; Yan JJ; Urangoo Z; Batbaatar G; Khosbayar T; Wu JJ
J Microbiol Immunol Infect; 2016 Oct; 49(5):692-700. PubMed ID: 26194952
[TBL] [Abstract][Full Text] [Related]
12. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H
Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768
[TBL] [Abstract][Full Text] [Related]
13. Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.
Poulou A; Voulgari E; Vrioni G; Koumaki V; Xidopoulos G; Chatzipantazi V; Markou F; Tsakris A
J Clin Microbiol; 2013 Oct; 51(10):3176-82. PubMed ID: 23850951
[TBL] [Abstract][Full Text] [Related]
14. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
15. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.
Liao K; Chen Y; Wang M; Guo P; Yang Q; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Xu Y
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):45-48. PubMed ID: 27773544
[TBL] [Abstract][Full Text] [Related]
16. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany.
Gröbner S; Linke D; Schütz W; Fladerer C; Madlung J; Autenrieth IB; Witte W; Pfeifer Y
J Med Microbiol; 2009 Jul; 58(Pt 7):912-922. PubMed ID: 19502377
[TBL] [Abstract][Full Text] [Related]
17. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
[TBL] [Abstract][Full Text] [Related]
18. In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase.
Cuzon G; Naas T; Guibert M; Nordmann P
Int J Antimicrob Agents; 2010 Mar; 35(3):265-8. PubMed ID: 20034767
[TBL] [Abstract][Full Text] [Related]
19. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Cai JC; Zhou HW; Zhang R; Chen GX
Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.
Woodford N; Tierno PM; Young K; Tysall L; Palepou MF; Ward E; Painter RE; Suber DF; Shungu D; Silver LL; Inglima K; Kornblum J; Livermore DM
Antimicrob Agents Chemother; 2004 Dec; 48(12):4793-9. PubMed ID: 15561858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]